Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management

Nuclear Medicine Communications

Volumn 29, Issue 4, 2008, Pages 367-373

  Basu, Sandip ^a   Houseni, Mohamed ^a   Alavi, Abass ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

CT; FDG; Malignancy; MRI; Parotid; PET; PET CT; Pleomorphic adenoma; Warthin's tumor

Indexed keywords

FLUORODEOXYGLUCOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND; PLEOMORPHIC ADENOMA; POSITRON EMISSION TOMOGRAPHY; SUBMANDIBULAR GLAND; WARTHIN TUMOR;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PAROTID GLAND; RADIOPHARMACEUTICALS; SALIVARY GLAND DISEASES;

EID: 43149108636     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f8147a     Document Type: Article

References (10)

1. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005; 234:879-885.
2. Keyes JW Jr, Harkness BA, Greven KM, Williams DW III, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994; 192:99-102.
3. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, et al. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 2005; 30:170-176.
4. Rubello D, Nanni C, Castellucci P, Rampin L, Farsad M, Franchi R, et al. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses? Panminerva Med 2005; 47:187-189.
5. Jadvar H, Bonyadlou S, Iagaru A, Colletti PM. FDG PET-CT demonstration of Sjogren's sialoadenitis. Clin Nucl Med 2005; 30:698-699.
6. Stahl A, Dzewas B, Schwaiger M, Weber WA. Excretion of FDG into saliva and its significance for PET imaging. Nuklearmedizin 2002; 41:214-216.
7. Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol Suppl 1998; 538:209-213.
8. Matsuda M, Sakamoto H, Okamura T, Nakai Y, Ohashi Y, Kawabe J, et al. Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland. Acta Otolaryngol Suppl 1998; 538:214-220.
9. Horiuchi M, Yasuda S, Shohtsu A, Ide M. Four cases of Warthin's tumor of the parotid gland detected with FDG PET. Ann Nucl Med 1998; 12:47-50.
10. Ozawa N, Okamura T, Koyama K, Nakayama K, Kawabe J, Shiomi S, et al. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99舁m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses. Radiat Med 2006; 24:41-49.